The combination of a protected blood transporting nanocarrier system and a tumor specific activation technology makes LiPlasome Pharma very competitive in a commercially attractive and dynamic anticancer market, where drug delivery systems will gain increasing importance over the coming years.
Living Cell is developing cell-based products to treat life threatening human diseases. The company has developed proprietary nanobiocapsules which allow encapsulated pig insulin producing cells, DiabeCell, to be implanted without the use of toxic immune suppressive drugs.
London Graphene Ltd was established in 2013 to develop advanced energy storage applications based on high quality graphene. The company has an option on some patents from the Department of Materials at the University of Oxford on CVD graphene.
The company develops, produces and distributes 3D analysis instruments based on the Digital Holographic Microscopy (DHM) technology. With this technology, microscopes combine nanometric resolution, real-time and non-invasive three dimensional observation